Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies

Breast Cancer

Volumn 17, Issue 1, 2010, Pages 9-16

  Takei, Hiroyuki ^a   Kurosumi, Masafumi ^a   Yoshida, Takashi ^a   Ishikawa, Yuko ^a   Hayashi, Yuji ^a   Ninomiya, Jun ^a   Tozuka, Katsunori ^a   Oba, Hanako ^a   Inoue, Kenichi ^a   Nagai, Shigenori ^a   Saito, Yoshihiro ^a   Kazumoto, Tomoko ^a   Saitoh, Jun Ichi ^a   Tabei, Toshio ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Intraoperative false negative SLNB; Recurrence; Sentinel lymph node biopsy (SLNB)

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; FROZEN SECTION; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; STAINING; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 73549122811     PISSN: 13406868     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12282-009-0154-4     Document Type: Article

References (38)

1. GH Lyman AE Giuliano MR Somerfield AB Benson 3rd DC Bodurka HJ Burstein AJ Cochran HS Cody 3rd SB Edge S Galper JA Hayman TY Kim CL Perkins DA Podoloff VH Sivasubramaniam RR Turner R Wahl WD Weaver AC Wolff EP Winer 2005 American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer J Clin Oncol 23 7703 7720 10.1200/JCO.2005.08.001 16157938 (Pubitemid 46291835)
2. T Kim AE Giuliano GH Lyman 2006 Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma: a metaanalysis Cancer 106 4 16 10.1002/cncr.21568 16329134 (Pubitemid 43033320)
3. U Veronesi G Paganelli G Viale A Luini S Zurrida V Galimberti M Intra P Veronesi P Maisonneuve G Gatti G Mazzarol C De Cicco G Manfredi JR FernViaez 2007 Sentinel-lymph node biopsy as a staging procedure in breast cancer: update of a randomized controlled study Lancet Oncol 7 983 989 10.1016/S1470-2045(06) 70947-0
4. DN Krag SJ Anderson TB Julian AM Brown SP Harlow T Ashikaga DL Weaver BJ Miller LM Jalovec TG Frazier RD Noyes A Robidoux HM Scarth DM Mammolito DR McCready EP Mamounas JP Costantino N Wolmark 2007 National surgical adjuvant breast and bowel project, technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881 888 10.1016/S1470-2045(07)70278-4 1:CAS:528: DC%2BD2sXhtFektbzM 17851130 (Pubitemid 47488052)
5. H Takei K Suemasu M Kurosumi K Uchida K Igarashi J Ninomiya R Naganuma T Kusawake N Sugamata H Matsumoto Y Higashi 2002 Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases Breast Cancer 9 344 348 10.1007/BF02967615 12459717
6. H Takei K Suemasu M Kurosumi Yoshida T HoriiY J Ninomiya M Yoshida Y Hagiwara M Kamimura Y Hayashi K Inoue T Tabei 2007 Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer Breast Cancer 14 16 24 10.2325/jbcs.14.16 17244989
7. H Takei M Kurosumi T Yoshida J Ninomiya Y Hagiwara M Kamimura Y Hayashi K Tozuka K Suemasu K Inoue T Tabei 2007 Current trends of sentinel lymph node biopsy for breast cancer-a surgeon's perspective Breast Cancer 14 362 370 10.2325/jbcs.14.362 17986801
8. BJ Grube AE Giuliano 2001 Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial Semin Surg Oncol 20 230 237 10.1002/ssu.1038 1:STN:280:DC%2BD3MvnvFGhtw%3D%3D 11523108 (Pubitemid 32830834)
9. JS Fant MD Grant SM Knox SA Livingston K Ridl RC Jones JA Kuhn 2003 Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection Ann Surg Oncol 10 126 130 10.1245/ASO.2003.04.022 12620906 (Pubitemid 40485931)
10. K Fournier A Schiller RR Perry C Laronga 2004 Micrometastasis in the sentinel lymph node of breast cancer does not mandate complete axillary dissection Ann Surg 239 859 863 10.1097/01.sla.0000128302.05898.a7 15166965 (Pubitemid 38669436)
11. AM Naik J Fey M Gemignani A Heerdt L Montgomery J Petrek E Port V Sacchini L Sclafani K VanZee R Wagman PI Borgen HS Cody 3rd 2004 The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 462 471 10.1097/01.sla.0000137130.23530.19 15319717 (Pubitemid 39121340)
12. JS Jeruss DJ Winchester SF Sener EM Brinkmann MM Bilimoria E Barrera Jr E Alwawi A Nickolov GM Schermerhorn DJ Winchester 2005 Axillary recurrence after sentinel node biopsy Ann Surg Oncol 12 34 40 10.1007/s10434-004-1164-2 15827776 (Pubitemid 40486639)
13. I Langer WR Marti U Guller H Moch F Harder D Oertli M Zuber 2005 Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy Ann Surg 241 152 158 15622003
14. RF Hwang AM Gonzalez-Angulo M Yi TA Buchholz F Meric-Bernstam HM Kuerer GV Babiera W Tereffe DD Liu KK Hunt 2007 Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection Cancer 110 723 730 10.1002/cncr.22847 17587208 (Pubitemid 47257646)
15. S Zakaria G Pantvaidya CA Reynolds CS Grant S Sterioff JH Donohue DR Farley TL Hoskin AC Degnim 2008 Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? Surgery 143 641 647 10.1016/j.surg.2007.10.023 18436012
16. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106
17. Takei H, Kurosumi M, Yoshida T, Ninomiya J, shikawa Y, Hayashi Y, Tozuka K, Asakawa H, Oba H, Inoue K, Tabei T. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer. Breast. 2009 [Epub ahead of print].
18. W Alkhatib C Connor F Fang 2007 Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) in predictive of a negative completion axillary lymph node dissection Am J Surg 194 856 859 10.1016/j.amjsurg.2007.08.029 18005784 (Pubitemid 350089940)
19. AK Rivers KA Griffith KK Hunt AC Degninm MS Sabel KM Diehl VM Cimmino AE Chang PC Lucas LA Newman 2006 Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node Ann Surg Oncol 13 36 44 10.1245/ASO.2006.03.080 16378156 (Pubitemid 43117643)
20. KJ Van Zee DM Manasseh JL Bevilacqua SK Boolbol JV Fey LK Tan PI Borgen HS Cody MW Kattan 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 10.1245/ASO.2003.03.015 14654469 (Pubitemid 40486808)
21. RF Hwang S Krishnamurthy KK Hunt N Mirza FC Ames B Feig HM Kuerer SE Singletary G Babiera F Meric JS Akins J Neely MI Ross 2003 Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 10 248 254 10.1245/ASO.2003.05.020 12679309 (Pubitemid 40486957)
22. A Pal E Provenzano SW Duffy SE Pinder AD Purushotham 2008 A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive Br J Surg 95 302 309 10.1002/bjs.5943 1:STN:280: DC%2BD1c7islSgtw%3D%3D 17876750
23. HE Kohrt RA Olshen HR Bermas WH Goodson DJ Wood S Henry RV Rouse L Bailey VJ Philben FM Dirbas JJ Dunn DL Johnson IL Wapnir RW Carson FE Stockdale NM Hansen SS Jeffery SLN Bay Area Study 2008 New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients BMC Cancer 8 66 10.1186/1471-2407-8-66 18315887 (Pubitemid 351566658)
24. J Park JV Fey AM Naik PI Borgen KJ Van Zee HS Cody 3rd 2007 A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 245 462 468 10.1097/01.sla.0000250439.86020.85 17435554 (Pubitemid 46673143)
25. H Takei K Suemasu M Kurosumi Y Horii J Ninomiya M Kamimura R Naganuma K Uchida K Igarashi K Inoue T Tabei 2006 Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer Breast Cancer 13 179 185 10.2325/jbcs.13.179 16755114
26. 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer Surg Today 36 219 224 10.1007/s00595-005-3128-y 1:CAS:528:DC%2BD28Xhs12hu7g%3D 16493529 (Pubitemid 43288713)
27. SE Singletary JL Connolly 2006 Breast cancer staging: working with the sixth edition of the AJCC cancer staging manual CA Cancer J Clin 56 37 47 10.3322/canjclin.56.1.37 16449185
28. M Kurosumi K Suemasu T Tabei K Inoue H Matsumoto N Sugamata Y Higashi 2001 Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast Oncol Rep 8 1051 1055 1:STN:280:DC%2BD3MvltVCnug%3D%3D 11496315
29. H Takei K Suemasu M Kurosumi Y Horii J Ninomiya M Yoshida Y Hagiwara K Inoue T Tabei 2006 Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer Breast J 12 Suppl 2 S157 S164 10.1111/j.1075-122X.2006.00329.x 16958996 (Pubitemid 44337463)
30. MS Pugliese JD Beatty RJ Tickman KH Allison MK Atwood J Szymonifka ZM Arthurs PP Huynh JH Dawson 2009 Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories Ann Surg Oncol 16 113 120 10.1245/s10434-008-0121-x 18949520
31. LK Tan D Giri AJ Hummer KS Panageas E Brogi L Norton C Hudis PI Borgen HS Cody 3rd 2008 Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 1803 1809 10.1200/JCO.2007.12.6425 18332473
32. CE Cox JV Kiluk AI Riker JM Cox N Allred DC Ramos EL Dupont V Vrcel N Diaz D Boulware 2008 Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 261 268 10.1016/j.jamcollsurg.2007.08.024 18222378
33. PH Spruit S Siesling MA Elferink EJ Vonk CJ Hoekstra 2007 Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up Radiat Oncol 2 40 10.1186/1748-717X-2-40 17971196
34. S Pejavar LD Wilson BG Haffty 2006 Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS + RT) Int J Radiat Oncol Biol Phys 66 1320 1327 17049182
35. S Galper A Recht B Silver MV Bernardo R Gelman J Wong SJ Schnitt JL Connolly JR Harris 2000 Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy Int J Radiat Oncol Biol Phys 48 125 132 10.1016/S0360-3016(00)00631-3 1:STN:280:DC%2BD3czps1alsg%3D%3D 10924981 (Pubitemid 30488222)
36. JS Wong AG Taghian JR Bellon A Keshaviah BL Smith EP Winer B Silver JR Harris 2008 Tangential radiotherapy without axillary surgery in early stage breast cancer: results of a prospective trial Int J Radiat Oncol Biol Phys 72 866 870 18394815
37. PJ Schlembach TA Buchholz MI Ross SM Kirsner GJ Salas EA Strom MD McNeese GH Perkins KK Hunt 2001 Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation Int J Radiat Oncol Biol Phys 51 671 678 1:STN:280:DC%2BD3MrltFGisQ%3D%3D 11597808
38. European Organization for Research and Treatment of Cancer. Phase III randomized study of complete axillary lymph node dissection versus axillary radiotherapy in sentinel lymph node positive women with operable invasive breast cancer. Available at http://www.clinicaltrials.gov/ct/show/NCT00014612.